Covid-19 Vaccine of Moderna Gets EMA Approval for Children Between 12 to 17 Years
The Spikevax vaccine developed by Moderna has got the green light from the European Medicines Agency (EMA) for its use in the children coming in the age group of 12 years to 17 years, which had been responsible for making it the second covid-19 vaccine jab for the adolescents for use in the continent of […]
Continue Reading